CAS: 50906-77-9; 3,3'-Disulfanediyldi(Propanehydrazide)

该化合物是一个化学化合物,其特点是二硫基结构,其特点是两种丙酸酸脂,由二硫基生物组联结,该化合物通常具有与氢氮化物有关的特性,包括能够在与碳基化合物发生反应时形成氢化衍生物;极地溶剂中溶解,由于氢氮化物具有参与氢联结的能力,这种溶解剂很常见;二硫基和氢氮化物功能组的存在表明生物化学学的潜在应用,特别是在交叉联结剂合成或有机合成的试剂中.此外,该化合物可能由于硫原子存在,从而能够形成氢氮化物衍生物衍生物衍生物,因此该化合物可能具有抗氧化性特性.在处理时,应参考安全数据,因为含氢氮化物的化合物可能具有敏感性并可能构成健康风险.

结构式图片

相似化合物

1002-19-3 6292-68-8 689-02-1

合成工艺路线路线简述

  • 合成目标产物 3,3'-Dithiobis(Propionohydrazide) 主要起始原料 3,3'-Dithiobis(Propionic Acid Ethyl) Ester
  • (文献来源)合成步骤主要原料 3,3'-Dithiobis(Propionic Acid Ethyl) Ester
3,3'-二氢氧啉酸置于乙醇,硫酸,一水合肼体系中,化学反应生成 3,3'-二硫代二(丙酰肼)
参考文献:Seyden-Penne,Annales De Chimie (Cachan,France),1958,Vol. <13>3,P. 599,631
标题:Seyden-Penne,Annales De Chimie (Cachan,France),1958,Vol. <13>3,P. 599,631

海关参考信息

专利信息


专利号:US-2015182634-A1
优先权日:2012-12-28
标 题:Molecular Design and Chemical Synthesis of Pharmaceutical-Ligands and Pharmaceutical-Pharmaceutical Analogs with Multiple Mechanisms of Action
发明人:COYNE CODY P; BEAR RYAN; JONES TONI
权利人:COYNE CODY P; BEAR RYAN; JONES TONI
摘要:Multi-phase and single-phase chemical reaction schemes have been developed for the synthesis of pharmaceutical-ligand analogs, pharmaceutical-pharmaceutical analogs, and similar molecular-molecular analogs that possess multiple mechanisms of action. The multi-phase organic chemical reaction schemes include relatively mild reaction conditions, high end product yields, and comparatively rapid completion of chemical reactions, which are all of particular utility for the synthesis of preparations including covalent pharmaceutical-receptor ligand or pharmaceutical-immunoglobulin analogs. Examples of pharmaceutical-ligand preparations that can be synthesized utilizing the multi-step chemical reaction schemes include covalent chemotherapeutic-ligand agents that possess selective targeted delivery properties and a capacity to exert additive and synergistic levels of cytotoxic anti-neoplastic potency. Pharmaceutical-pharmaceutical analogs, including chemotherapeutic-chemotherapeutic analogs that are capable of exerting multiple mechanisms of action, can be synthesized using either of the described multi-phase or single-phase organic chemistry reaction schemes. Each of these representative examples has utility against a spectrum of disease states including, for example, neoplastic conditions such as mammary adenocarcinoma/carcinoma, ovarian carcinoma, prostatic carcinoma, intestinal carcinoma, melanoma, leukemia, myeloma, and lymphoma.

专利号:US-8691793-B2
优先权日:2003-12-04
标题 :Modified macromolecules and associated methods of synthesis and use
发明人:PRESTWICH GLENN D; SHU XIAO ZHENG; LIU YANCHUN
权利人:PRESTWICH GLENN D; SHU XIAO ZHENG; LIU YANCHUN; UNIV UTAH RES FOUND
摘要:Described herein are compounds such as macromolecules that have been modified in order to facilitate crosslinking and methods of making and using thereof.

专利号:US-2008025950-A1
优先权日:2003-12-04
标 题:Modified Macromolescules and Associated Methods of Synthesis and Use

专利号:US-7981871-B2
优先权日:2003-12-04
标 题 :Modified macromolescules and associated methods of synthesis and use

专利号:US-2012142907-A1
优先权日:2003-12-04
标 题 :Modified macromolecules and associated methods of synthesis and use
盐城云涛化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.yuntao-chem.com
企业联系电话:0515-83090980;13512592619👤
📞盐城云涛化工有限公司 ⚠️参考联系方式
联系人:郭先生 13512592619
电话:0515-83090980;13512592619
手机:13512592619
传真:0515-83090980
邮箱:2838893166@qq.com
通信地址: 江苏省盐城市解放南路239号汇景大厦613室
邮编: 224011
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:江苏省盐城市解放南路239号汇景大厦613室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1007/s44174-023-00118-4
摘要:Paiva MTP, Kishima JOF, Silva JBMD, Mantovan J, Colodi FG, Mali S. Crosslinking Methods in Polysaccharide-Based Hydrogels for Drug Delivery Systems. Biomedical Materials & Devices. 2023 Jul 26;2(1):288–306. doi: 10.1007/s44174-023-00118-4.
参考文献:10.1007/12_2024_181
摘要:Arya Lakshmi VV, Jayakumar R. Chitosan: The Versatile Biomaterial. 2024. In: Advances in Polymer Science.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知